AMENDMENT TO EMPLOYMENT OFFER LETTER FOR CHANGE OF CONTROLEmployment Agreement • May 7th, 2019 • Foamix Pharmaceuticals Ltd. • Medicinal chemicals & botanical products • New Jersey
This Letter Agreement is made on May 6, 2019 between Mutya Harsch (“Executive”), Foamix Pharmaceuticals Ltd. (“Foamix”) and Foamix Pharmaceuticals Inc., a wholly-owned subsidiary of Foamix (“Foamix Pharmaceuticals Inc.”). Reference is made to the Offer Employment Letter (the “Offer Letter”) dated as of November 1, 2017 between Executive and Foamix Pharmaceuticals Inc.
AMENDMENT TO EMPLOYMENT AGREEMENT FOR CHANGE OF CONTROLEmployment Agreement • May 7th, 2019 • Foamix Pharmaceuticals Ltd. • Medicinal chemicals & botanical products
This Letter Agreement is made on May 6, 2019 between ILAN HADAR (“Employee”) and Foamix Pharmaceuticals Ltd. (“Foamix”). Reference is made to the employment agreement (the “Employment Agreement”) dated as of September 13, 2017, between Executive and Foamix.
ContractLease • May 7th, 2019 • Foamix Pharmaceuticals Ltd. • Medicinal chemicals & botanical products
FIRST AMENDMENT TO LEASE (the “First Amendment”) dated as of March 13, 2019, between S/K 520 ASSOCIATES (the “Landlord”), whose mailing address is P.O. Box 6872, 520 US Highway 22, Bridgewater, NJ 08807, and FOAMIX PHARMACEUTICALS INC., (the “Tenant”), having an office at 520 US Highway 22, Bridgewater, NJ 08807.
